Hap Trading, LLC Athira Pharma, Inc. Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$8.96 - $13.51 $15,482 - $23,345	1,728 Added 10.9%	17,587 $237,000
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $110,241 - $197,040	-12,022 Reduced 43.12%	15,859 $207,000
Q3 2021 Nov 10, 2021	BUY	$9.15 - $11.09 $255,111 - $309,200	27,881 New	27,881 $262,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.